Full Press Release Details
4D Molecular Therapeutics Raises $90 Million Series B Financing.
FDMT
4D Molecular Therapeutics Raises $90 Million Series B Financing
Key Takeaway: 4D Molecular Therapeutics Raises $90 Million Series B Financing
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+128%
120-day peak, hindsight
Typical move
11.2%
average across 9 past catalysts
Cash runway
~18 mo
Low dilution risk
Lead asset
4D-150 IVT
Phase 3 · Macular Neovascularization Secondary to Age-Related Macular Degeneration